Actionable companion · Assessment & reasoning
From AI evidence to responsible practice: GenAI-Supported Virtual Patients in Health Care Education: Systematic Review
AI-assisted editorial implementation guide, separate from the original research. Proposed actions are not findings or recommendations attributed to the source authors. No independent peer review of this guide is asserted.
Evidence and context
Title and abstract screening; stage labels describe reported settings, not verified numerical ages. Design labels require full-text appraisal. Reported stage(s): Age / stage not established. Verify the participants, intervention and comparator before applying this study in a new setting.
Original authors’ abstract, reproduced under the linked source license:
Abstract Background Generative artificial intelligence (GenAI) is enhancing virtual patient simulations in health care education by enabling dynamic, adaptive interactions, reshaping how clinical skills are taught. A synthesis of the current evidence is needed to guide implementation and future research, given the pace of technological advancement. Objective This systematic review aims to synthesize empirical research on the design, implementation, and educational impact of GenAI-supported virtual patients in health care education. Methods A systematic search was conducted across 5 databases (CINAHL, Medline, Embase, Scopus, and Web of Science) from their inception to March 19, 2026. Reference lists of included studies and relevant systematic reviews were also screened. Peer-reviewed studies in English that evaluated GenAI-supported virtual patients using quantitative or mixed methods were included. Two reviewers independently screened studies and extracted data. Study quality and risk of bias were assessed critically using JBI (Joanna Briggs Institute) checklists, with disagreements resolved by consensus. Results A total of 15 studies met the inclusion criteria (total participants N=645), spanning health care disciplines, including nursing, medicine, pharmacy, radiography, and medical first-responder training. The virtual patients varied in design; input modalities included text (9 studies), voice (5 studies), or hybrid (1 study); output was text (9 studies), speech (5 studies), or both (1 study); 6 studies used 3D-embodied avatars, while 9 used nonembodied interfaces. A total of 13 studies used OpenAI GPT models (eg, ChatGPT), 1 used a fine-tuned model from a different provider, and 1 evaluated multiple model families (Claude, GPT, and open-source). Further, 6 studies used controlled experimental designs, including 3 randomized controlled trials (RCTs); the remainder were cross-sectional or prepost evaluations. Primary outcomes included user perceptions (14 studies), communication skills (4 studies), clinical reasoning (3 studies), and performance (7 studies). In controlled comparisons, GenAI-supported virtual patients consistently improved outcomes relative to control conditions: for example, enhanced clinical decision-making (RCT, n=21), ophthalmology history-taking skills (RCT, n=26), and medical history-taking performance (crossover RCT, n=20). The evidence base is characterized by brief intervention durations, a predominant reliance on single-session interactions, and a general lack of underpinning educational theory. No meta-analysis was performed due to the limited number of studies and significant heterogeneity in designs, interventions, and outcome measures. Conclusions The evidence supports the feasibility and acceptability of GenAI-supported virtual patients, with positive learner perceptions and promising outcomes for skills development. However, critical limitations remain in emotional-behavioral complexity, simulation adaptability, and research design rigor (eg, limited use of control groups and validated instruments). The review offers educators, instructional designers, and policymakers actionable insights for integrating dynamic, artificial intelligence–driven simulations while identifying crucial gaps—such as the need for theoretical grounding, longitudinal studies, and standardized design protocols—that must be addressed for safe and effective implementation.
What kind of evidence is this?
Supporting AI learning science · Evidence synthesis
Stage: Age / stage not established. Screening labels describe reported context and study-design language. They are not a risk-of-bias rating or proof of effectiveness for an age band.
Study methods · source passage
This review was conducted and reported in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 statement and its expanded checklist (Checklist 1) [25], as well as synthesis without meta-analysis (Multimedia Appendix 1) [26]. The protocol was registered and published in the Open Science Framework repository [27].
Limitations and uncertainty · source passage
Despite their promise, the GenAI-supported virtual patients reviewed exhibit several inherent limitations. Critically, behavioral and emotional complexity remains underdeveloped. While some avatars [424446] incorporated basic movements or facial expressions, these were often simplistic and failed to fully replicate the nuanced nonverbal cues (eg, subtle pain indicators, authentic gaze patterns, and culturally specific gestures) essential for holistic clinical assessment and empathy training. For instance, Mool et al [46] noted that their 3D avatar was largely static within the examination room environment, with no description of physical movement. Emotional responsiveness was largely superficial, relying on prescripted ranges or simplistic vocalizations [3842], rather than dynamically adapting emotional states based on learner interaction or physiological parameters. Furthermore, adaptability beyond dialog was constrained; virtual patients struggled to simulate evolving physical symptoms (eg, changing breath sounds and deteriorating vital signs) or accurately respond to physical examination maneuvers performed by learners within simulations. Memory and longitudinal consistency across interactions were absent, preventing virtual patients from recalling prior conversations or learner actions to build continuity. Finally, the underlying GenAI models (predominantly ChatGPT variants) introduced inherent biases and factual inaccuracies in medical content, alongside potential cultural insensitivities, raising concerns about the reliability and safety of the clinical scenarios portrayed. These limitations collectively restrict the virtual patients’ ability to fully mirror the dynamism and unpredictability of real patient encounters.
Design the system before the pilot
Use this study to inform a learning mechanism or implementation question. It is not direct evidence that autonomous agents improve learning. Keep the proposed agent behavior separate from what the source actually tested.
- Use common rubrics, blind scoring where feasible and a fresh unaided reasoning task. Document permissible assistance and avoid treating AI-detector scores as proof of misconduct.
- Co-design accommodations with learners and specialists. Check access and error burden across groups without inferring subgroup effectiveness from small or unreported samples.
A 90-day district pilot
- Days 1–15 · Appraise. Have the curriculum lead and a teacher read the methods and limitations. Record the study design, sample, comparator, outcomes and evidence gaps. Define a local question that the study can help inform.
- Days 16–30 · Design. Treat the paper as background evidence until its population is verified in the full text. Do not assign an age-specific intervention or extend adult results to children. Name an accountable owner and set the baseline, success threshold and budget before implementation.
- Days 31–60 · Test. Start with a small voluntary cohort, preserve an accessible non-AI route and require teacher review. Use synthetic or de-identified examples; approve data handling and tool terms through district processes.
- Days 61–90 · Decide. Extract the participant ages or education stage, recruitment, task and comparator before selecting a local pilot. If these cannot be established, retain the paper for design discussion rather than age-band efficacy claims. Compare with baseline, document uncertainty and stop or revise if learning worsens, access is unequal or critical errors persist.
The board decision brief
Report the learning problem, evidence quality, participating population, total cost including review time, measured benefit, errors, access differences and remaining uncertainties. Make a dated recommendation to stop, revise or expand. A positive perception survey alone does not establish learning improvement.
Attribution and reuse
Juming Jiang; Megan Zichen Ye; Tyrone Tai-On Kwok; Janet Yuen Ha Wong. GenAI-Supported Virtual Patients in Health Care Education: Systematic Review. Journal of Medical Internet Research (2026-05-07). https://doi.org/10.2196/82756
Companion prepared 2026-11-01. Original authorship and DOI are preserved. The abstract is an attributed source extract; the implementation plan is new AI-assisted editorial material, offered under the same CC BY 4.0 license. This guide has not undergone independent peer review.